Detalles de la búsqueda
1.
Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome.
Blood
; 113(12): 2765-3775, 2009 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-19096012
2.
Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial.
J Clin Oncol
; 34(17): 2028-36, 2016 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27114593
3.
Identification of MUM1 as a prognostic immunohistochemical marker in follicular lymphoma using computerized image analysis.
Hum Pathol
; 45(10): 2085-93, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25149549
4.
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.
J Clin Oncol
; 32(12): 1188-94, 2014 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24637998
5.
Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin's lymphoma.
J Clin Oncol
; 24(24): 3880-6, 2006 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16864854
Resultados
1 -
5
de 5
1
Próxima >
>>